Clinical trial of the future: How secondary data could add speed and accuracy to trial designs
Editor’s note: On International Clinical Trials day, Cynthia Verst, the president of Clinical Operations at Durham-based Quintiles (NYSE: Q), writes that the use of secondary data earlier in the research process can lead to “smarter, faster and more cost-sensitive clinical trials.” DURHAM, N.C. – Today is International Clinical Trials Day, a day in which we celebrate the great achievements of clinical researchers who bring life-saving treatments to fruition, and acknowledge the work we are doing today to make the trials of the future even more effective. For many of us, the key to that efficiency is speed. We all...
Read More
